Sigma receptors and iboga alkaloids.
Bowen
W D
WD
Unit on Receptor Biochemistry and Pharmacology, Laboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D020013:Calcium Signaling / Q000187:drug effects; D006801:Humans; D007050:Ibogaine / Q000378:metabolism / Q000494:pharmacology*; D020287:In Situ Nick-End Labeling; D017480:Receptors, sigma / Q000187:drug effects* / Q000502:physiology; D030014:Tabernaemontana
D000470:Alkaloids; D017480:Receptors, sigma; C106107:sigma-2 receptor; D007050:Ibogaine; D002118:Calcium